Phase II study of paclitaxel and gemcitabine in advanced non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Lazaro, M [1 ]
Jorge, M [1 ]
Castellanos, J [1 ]
机构：
[1] Hosp Xeral Cies, Dept Med Oncol, Vigo, Spain
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
493P
引用
收藏
页码：109 / 109
页数：1
相关论文
共 50 条
  • [1] Phase II study of oxaliplatin and paclitaxel in advanced non-small cell lung cancer (NSCLC).
    Mauer, AM
    Otterson, G
    Rudin, CM
    Villalona, M
    Ansari, RH
    Szeto, L
    Vokes, EE
    CLINICAL CANCER RESEARCH, 2000, 6 : 4576S - 4576S
  • [2] Gemcitabine plus cisplatin in advanced non-small cell lung cancer (NSCLC): A phase II study
    Orlandi-Jorquera, L
    Orlandi, F
    Galaz, P
    Gamargo, C
    Salman, P
    Yanez, M
    ANNALS OF ONCOLOGY, 1998, 9 : 101 - 101
  • [3] Paclitaxel/gemcitabine versus paclitaxel/vinorelbine in advanced non-small cell lung cancer (NSCLC): A phase III randomized study
    Kosmidis, P. A.
    Timotheadou, E.
    Koutras, A.
    Pentheroudakis, G.
    Christodoulou, C.
    Dimopoulos, A. M.
    Bafaloukos, D.
    Samantas, E.
    Pectasides, D.
    Syrigos, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [4] Carboplatin plus gemcitabine followed by weekly paclitaxel in advanced and metastatic non-small cell lung cancer (NSCLC): A phase II study
    Tjan-Heijnen, V
    Timmer-Bonte, J
    van der Drift, M
    van Leeuwen, F
    de Boo, T
    Wagenaar, M
    van Die, L
    Bussink, J
    LUNG CANCER, 2005, 49 : S272 - S272
  • [5] Gemcitabine, ifosfamide and paclitaxel in advanced/metastatic non-small cell lung cancer patients: a phase II study
    Piantedosi, F. V.
    Caputo, F.
    Mazzarella, G.
    Gilli, M.
    Pontillo, A.
    D'Agostino, D.
    Campbell, S.
    Marsico, S. A.
    Bianco, A.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 61 (05) : 803 - 807
  • [6] Gemcitabine, ifosfamide and paclitaxel in advanced/metastatic non-small cell lung cancer patients: a phase II study
    F. V. Piantedosi
    F. Caputo
    G. Mazzarella
    M. Gilli
    A. Pontillo
    D. D’Agostino
    S. Campbell
    S. A. Marsico
    A. Bianco
    Cancer Chemotherapy and Pharmacology, 2008, 61 : 803 - 807
  • [7] Phase II study of vinorelbine (VNR) and gemcitabine (GEM) in advanced non-small cell lung cancer (NSCLC)
    Firvida, JL
    Rodriguez, R
    Sabin, P
    Castellanos, J
    Mata, JG
    Salgado, M
    Vazquez, S
    Lazaro, M
    Delgado, FM
    ANNALS OF ONCOLOGY, 1998, 9 : 97 - 97
  • [8] A phase II of gemcitabine in advanced non-small cell lung cancer
    Koynov, K
    Tzekova, V
    Mincheva, N
    Scherer, A
    Krejcy, K
    3RD INTERNATIONAL CONGRESS ON LUNG CANCER, 1998, : 231 - 234
  • [9] Phase II study of weekly gemcitabine in advanced non-small cell lung cancer
    Halme, M
    Jekunen, A
    Tamminen, K
    Mattson, K
    RESPIRATORY MEDICINE, 1997, 91 (07) : 423 - 426
  • [10] Phase II study of Gemcitabine, ifosfamide and cisplatin (GIP) in patients with advanced non-small cell lung cancer (NSCLC)
    De las Penas, R
    Busquier, I
    Munarriz, J
    Lopez, A
    Llorente, R
    Alberola, V
    Frau, A
    ANNALS OF ONCOLOGY, 1998, 9 : 88 - 88
12345